Navigation Links
BioHealth Innovation, Inc. Forms Commercial Relevance Advisory Board to Help Advance Market-Relevant Innovations in Central Maryland

ROCKVILLE, Md., Feb. 27, 2013 /PRNewswire/ -- BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding in Central Maryland, announced today the formation of its Commercial Relevance Advisory Board (CRAB). Members of the CRAB represent diverse business and academic organizations from throughout the region, such as venture capital firm New Enterprise Associates, Ernst & Young, the Howard Hughes Medical Institute, the University of Maryland (UMD), Johns Hopkins University, and leading biotechnology companies.

The CRAB will assist BHI in evaluating market-relevant research and product development opportunities as well as help determine the commercial applicability of emerging entrepreneurs, companies and their science or technology. BHI will utilize feedback from CRAB members as part of its due diligence process for establishing formal client relationships and potentially future investments.

CRAB members include:

  • Jesse  Baumgold, Principal, BioEnterprises, LLC
  • Dan Bednarik , Senior Director, MEU Operations, Intrexon Corporation
  • Judy Britz , Executive Director, Maryland Biotechnology Center
  • Steve Canaras, Partner, Ernst & Young
  • Edward Chan , NaviMed Capital
  • Martha Connolly , Director, Maryland Industrial Partnerships (MIPS), UMD
  • Tom Dann , Managing Director of Equity Funds, Maryland Venture Fund, Maryland State Department of Business & Economic Development
  • Brian Darmody , Associate Vice President for Research and Economic Development, UMD
  • Doug Doerfler , President & CEO, MaxCyte Inc.
  • Moustapha El Amine , Senior Director, Scientific Services, Emergent BioSolutions
  • Bill Enright , President & CEO, Vaxin Inc.
  • Elizabeth Good , Director, Ventures, Johns Hopkins University
  • Jim Hughes , Chief Enterprise and Economic Development Officer/Vice President at UMD Baltimore, & Director, UM Ventures
  • Rachel King , CEO, GlycoMimetics, Inc.
  • James Lee , Executive Vice President/CFO, Adventist Healthcare
  • Raj Malik, Co-Founder & CEO, Infusd
  • Ken Malone , Principal, Early Charm Ventures, LLC
  • Arumani Manisundaram, Director, Center of Connected Health, Adventist Healthcare
  • Chris Meenan , Director, Clinical Informatics, School of Medicine, UMD
  • Arkesh Mehta, CEO, Chikujee Therapeutics
  • Cheryl Moore , Executive Vice President & COO, Howard Hughes Medical Institute
  • Sara Nayeem , Principal, New Enterprise Associates
  • Jerry Parrott , Principal, Jerry Parrott LLC and Chair and President, Maryland Health Care Product Development Corporation
  • Joana Rosario , Principal, J. Rosario et Al, LLC
  • Rob Rosenbaum , President & Executive Director, TEDCO
  • Vin Singh , CEO, Next Healthcare, Inc.
  • Gayatri Varma , Executive Director, Office of Technology Commercialization, UMD

About BioHealth Innovation, Inc.
BioHealth Innovation, Inc., is a regional innovation intermediary focused on commercializing market-relevant bio-health innovations and increasing access to early-stage funding in Maryland. Learn more at

SOURCE BioHealth Innovation, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. BioHealth Innovation, Inc. Appoints Qiagens Douglas Liu to Board of Directors
2. Economic Alliance of Greater Baltimore Inks Business Partnership with BioHealth Innovation to Bring Health and Life Sciences Research to Market
3. BioHealth Innovation, Inc. Caps Next Phase Of Development With Move To New Headquarters And Addition Of Staff
4. Two Baltimore Business Leaders are BioHealth Innovation, Inc.s Newest Board Members
5. New Report: "Innovations in Drug Delivery - Broad-based Proprietary Technology Platforms to Address Delivery Efficiency and Improve Patient Compliance" Now Available at
6. The Alliance for Regenerative Medicine forms Tissue Engineering and Biomaterials Committee
7. Lucintel Performs Competitive Analysis on Top Five Global Consumer Electronic Companies
8. WaferGen Reports Third Quarter 2011 Financial Results and Announces New Commercialization Strategy
9. OvaGene Oncology Collaborates With Moffitt Cancer Center to Develop and Commercialize microRNAs Associated With Chemotherapeutic Drug Response
10. Cellular Dynamics Announces Commercial Launch of iCell® Neurons for Neuroscience Drug Discovery
11. ReproCELL Licensed Commercialization Right on Human iPS Cell Derived Hepatocytes - Expected Launch in Q2 2012
Post Your Comments:
(Date:6/23/2016)... 2016   EpiBiome , a precision microbiome engineering ... debt financing from Silicon Valley Bank (SVB). The financing ... advance its drug development efforts, as well as purchase ... "SVB has been an incredible strategic partner to us ... bank would provide," said Dr. Aeron Tynes Hammack ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample tracking software ... State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. , ... Tremblay, President and COO of STACS DNA. “In further expanding our capacity as a ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... June 23, 2016 ... 2016;12(1):22-8 Published recently ... peer-reviewed journal from touchONCOLOGY, Andrew D Zelenetz ... of cancer care is placing an increasing burden ... expensive biologic therapies. With the patents on many ...
Breaking Biology Technology:
(Date:4/26/2016)... BANGALORE, India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a ... ), and Onegini today announced a partnership to ... banking solutions.      (Logo: ... banks to provide their customers enhanced security to ...
(Date:4/14/2016)... Israel , April 14, 2016 ... Authentication and Malware Detection, today announced the appointment of ... assumed the new role. Goldwerger,s leadership appointment ... on the heels of the deployment of its platform ... BioCatch,s behavioral biometric technology, which discerns unique cognitive and ...
(Date:3/23/2016)... WAKEFIELD, Massachusetts , March 23, 2016 ... kombiniert im Interesse erhöhter Sicherheit Gesichts- und ... Xura, Inc. (NASDAQ: MESG ... heute bekannt, dass das Unternehmen mit SpeechPro ... insbesondere aus der Finanzdienstleistungsbranche, wird die Möglichkeit ...
Breaking Biology News(10 mins):